These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39091353)

  • 101. Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.
    Feng WH; Chang YC; Lin YH; Chen HL; Chang HM; Chu CS
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562942
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Implications of anemia in patients undergoing PCI with Impella-support: insights from the PROTECT III study.
    Falah B; Redfors B; Zhao D; Bharadwaj AS; Basir MB; Thompson JB; Patel RAG; Schonning MJ; Abu-Much A; Zhang Y; Batchelor WB; Grines CL; O'Neill WW
    Front Cardiovasc Med; 2024; 11():1429900. PubMed ID: 39091353
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
    Abu-Much A; Grines CL; Chen S; Batchelor WB; Zhao D; Falah B; Maini AS; Redfors B; Bellumkonda L; Bharadwaj AS; Moses JW; Truesdell AG; Zhang Y; Zhou Z; Baron SJ; Lansky AJ; Basir MB; O'Neill WW; Cohen DJ
    Int J Cardiol; 2024 Dec; 417():132555. PubMed ID: 39270940
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.
    Bharadwaj AS; Abu-Much A; Maini AS; Zhou Z; Li Y; Batchelor WB; Grines CL; Baron SJ; Redfors B; Lansky AJ; Basir MB; O'Neill WW
    Circ Cardiovasc Interv; 2024 Jul; 17(7):e013503. PubMed ID: 38708609
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Right Ventricular Dysfunction in Patients Undergoing High-Risk PCI with Impella.
    Rommel KP; Bonnet G; Bellumkonda L; Lansky AJ; Zhao D; Thompson JB; Zhang Y; Redfors B; Lurz PC; Granada JF; Bharadwaj AS; Basir MB; O'Neill WW; Burkhoff D
    J Card Fail; 2024 Oct; 30(10):1244-1254. PubMed ID: 39389734
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
    Carson JL; Brooks MM; Hébert PC; Goodman SG; Bertolet M; Glynn SA; Chaitman BR; Simon T; Lopes RD; Goldsweig AM; DeFilippis AP; Abbott JD; Potter BJ; Carrier FM; Rao SV; Cooper HA; Ghafghazi S; Fergusson DA; Kostis WJ; Noveck H; Kim S; Tessalee M; Ducrocq G; de Barros E Silva PGM; Triulzi DJ; Alsweiler C; Menegus MA; Neary JD; Uhl L; Strom JB; Fordyce CB; Ferrari E; Silvain J; Wood FO; Daneault B; Polonsky TS; Senaratne M; Puymirat E; Bouleti C; Lattuca B; White HD; Kelsey SF; Steg PG; Alexander JH;
    N Engl J Med; 2023 Dec; 389(26):2446-2456. PubMed ID: 37952133
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021.
    GBD 2021 Anaemia Collaborators
    Lancet Haematol; 2023 Sep; 10(9):e713-e734. PubMed ID: 37536353
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Sex Differences in pLVAD-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the PROTECT III Study.
    Shah T; Abu-Much A; Batchelor WB; Grines CL; Baron SJ; Zhou Z; Li Y; Maini AS; Redfors B; Hussain Y; Wollmuth JR; Basir MB; O'Neill WW; Lansky AJ
    JACC Cardiovasc Interv; 2023 Jul; 16(14):1721-1729. PubMed ID: 37409991
    [TBL] [Abstract][Full Text] [Related]  

  • 109. High Prevalence of Geriatric Conditions Among Older Adults With Cardiovascular Disease.
    Aïdoud A; Gana W; Poitau F; Debacq C; Leroy V; Nkodo JA; Poupin P; Angoulvant D; Fougère B
    J Am Heart Assoc; 2023 Jan; 12(2):e026850. PubMed ID: 36628962
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices.
    O'Neill WW; Anderson M; Burkhoff D; Grines CL; Kapur NK; Lansky AJ; Mannino S; McCabe JM; Alaswad K; Daggubati R; Wohns D; Meraj PM; Pinto DS; Popma JJ; Moses JW; Schreiber TL; Magnus Ohman E
    Am Heart J; 2022 Jun; 248():139-149. PubMed ID: 35192839
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
    Razuk V; Camaj A; Cao D; Nicolas J; Hengstenberg C; Sartori S; Zhang Z; Power D; Beerkens F; Chiarito M; Meneveau N; Tron C; Dumonteil N; Widder JD; Ferrari M; Violini R; Stella PR; Jeger R; Anthopoulos P; Mehran R; Dangas GD
    Catheter Cardiovasc Interv; 2021 Nov; 98(6):E870-E880. PubMed ID: 33909348
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support.
    Amin AP; Spertus JA; Curtis JP; Desai N; Masoudi FA; Bach RG; McNeely C; Al-Badarin F; House JA; Kulkarni H; Rao SV
    Circulation; 2020 Jan; 141(4):273-284. PubMed ID: 31735078
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.
    Faggioni M; Baber U; Sartori S; Chandrasekhar J; Cohen DJ; Henry TD; Claessen BE; Dangas GD; Gibson CM; Krucoff MW; Vogel B; Moliterno DJ; Sorrentino S; Colombo A; Chieffo A; Kini A; Farhan S; Ariti C; Witzenbichler B; Weisz G; Steg PG; Pocock S; Mehran R
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007133. PubMed ID: 30998384
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The link between anemia and adverse outcomes in patients with acute coronary syndrome.
    Guedeney P; Sorrentino S; Claessen B; Mehran R
    Expert Rev Cardiovasc Ther; 2019 Mar; 17(3):151-159. PubMed ID: 30712411
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Hospital Variation in the Utilization of Short-Term Nondurable Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock.
    Strom JB; Zhao Y; Shen C; Chung M; Pinto DS; Popma JJ; Cohen DJ; Yeh RW
    Circ Cardiovasc Interv; 2019 Jan; 12(1):e007270. PubMed ID: 30608880
    [TBL] [Abstract][Full Text] [Related]  

  • 116. The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure.
    Vetrovec GW; Anderson M; Schreiber T; Popma J; Lombardi W; Maini B; Moller JE; Schäfer A; Dixon SR; Hall S; Ohman EM; Mindrescu C; Moses J; O'Neill W
    Am Heart J; 2018 May; 199():115-121. PubMed ID: 29754648
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Anemia and Acute Coronary Syndrome: Time for Intervention Studies.
    Farhan S; Baber U; Mehran R
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27866165
    [No Abstract]   [Full Text] [Related]  

  • 118. Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.
    Kirtane AJ; Doshi D; Leon MB; Lasala JM; Ohman EM; O'Neill WW; Shroff A; Cohen MG; Palacios IF; Beohar N; Uriel N; Kapur NK; Karmpaliotis D; Lombardi W; Dangas GD; Parikh MA; Stone GW; Moses JW
    Circulation; 2016 Aug; 134(5):422-31. PubMed ID: 27482004
    [TBL] [Abstract][Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.